CymitQuimica logo
Apoptose

Apoptose

Les inhibiteurs de l'apoptose sont des composés qui empêchent ou retardent le processus de mort cellulaire programmée, connu sous le nom d'apoptose. Ces inhibiteurs sont essentiels pour étudier les mécanismes de survie cellulaire et sont utilisés pour enquêter sur les maladies où l'apoptose est dysrégulée, telles que le cancer, les troubles neurodégénératifs et les maladies auto-immunes. En modulant l'apoptose, ces inhibiteurs peuvent aider au développement de thérapies visant à contrôler la mort cellulaire. Chez CymitQuimica, nous offrons une sélection complète d'inhibiteurs de l'apoptose de haute qualité pour soutenir vos recherches en biologie cellulaire, oncologie et domaines connexes.

Sous-catégories appartenant à la catégorie "Apoptose"

Affichez 6 plus de sous-catégories

6170 produits trouvés pour "Apoptose"

Trier par

Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
produits par page.
  • p-MPPF

    CAS :
    p-MPPF is a 5-HT antagonist that can be used to study neurological diseases.
    Formule :C25H27FN4O2
    Degré de pureté :99.92%
    Couleur et forme :Solid
    Masse moléculaire :434.51

    Ref: TM-T69750L

    1mg
    201,00€
    5mg
    497,00€
    10mg
    701,00€
    25mg
    1.094,00€
    50mg
    1.508,00€
    100mg
    1.931,00€
  • CIGB-300

    CAS :
    CIGB-300 (P15-Tat) is an anti-casein kinase 2 (CK2) peptide that exhibits anticancer properties by disrupting the phosphorylation activity of protein kinase CK2. The compound induces apoptosis in various tumor cell lines, making it valuable for research in cancer therapy.
    Formule :C127H215N53O30S3
    Couleur et forme :Solid
    Masse moléculaire :3060.6

    Ref: TM-TP2765

    10mg
    À demander
    50mg
    À demander
  • MMRi62

    CAS :
    MMRi62, a MDM2-MDM4 inhibitor, induces ferroptosis and autophagy in PDAC, degrades FTH1 and mutant p53, and inhibits KRAS/TP53 mutant PDAC in mice.
    Formule :C21H15Cl2N3O
    Degré de pureté :99.87%
    Couleur et forme :Soild
    Masse moléculaire :396.27

    Ref: TM-T60202

    1mg
    35,00€
    5mg
    70,00€
    10mg
    104,00€
    25mg
    202,00€
    50mg
    329,00€
    100mg
    525,00€
    500mg
    1.121,00€
    1mL*10mM (DMSO)
    78,00€
  • Ac-Trp-Glu-His-Asp-Aldehyde

    CAS :
    Ac-Trp-Glu-His-Asp-Aldehyde is a powerful and selective inhibitor of caspase-1, demonstrating a K_i value of 56 pM [1] [2].
    Formule :C28H33N7O9
    Couleur et forme :Solid
    Masse moléculaire :611.6

    Ref: TM-T76600

    5mg
    À demander
    50mg
    À demander
  • Anti-inflammatory agent 74


    Anti-inflammatory agent 74 (B5) is known for its ability to inhibit NO, IL-6, and TNF-α, with IC50 values of 10.88 μM and 4.93 μM for NO and IL-6, respectively. It alleviates acute lung injury (ALI) by modulating inflammatory mediators and inhibiting the MAPK and NF-κB signaling pathways.
    Formule :C41H51NO14
    Masse moléculaire :781.33096

    Ref: TM-T208962

    10mg
    À demander
    50mg
    À demander
  • CQ627


    CQ627 is a molecular glue that targets the degradation of RIOK2. It effectively recruits the E3 ubiquitin ligase RNF126, inducing the proteasomal degradation of RIOK2 via the ubiquitin-proteasome system (UPS) in MOLT4 leukemia cell lines, with a DC50 value of 410 nM. Additionally, CQ627 induces apoptosis in a dose-dependent manner in these cells, blocking the cell cycle at the G2/M phase, and exhibits antiproliferative activity across various cancer cell lines. It also demonstrates in vivo anticancer activity in MOLT4 xenograft mouse models.
    Formule :C36H27F4N7O4
    Couleur et forme :Solid
    Masse moléculaire :697.638

    Ref: TM-T204921

    10mg
    À demander
    50mg
    À demander
  • DSTYSLSSTLTLSK TFA


    DSTYSLSSTLTLSK TFA detects infliximab, a chimeric IgG1 antibody targeting TNF-α.
    Formule :C66H108F3N15O28
    Couleur et forme :Solid
    Masse moléculaire :1616.64

    Ref: TM-T76209

    5mg
    À demander
    50mg
    À demander
  • Reproxalap

    CAS :

    Reproxalap (NS-2) is a dry eye treatment that neutralizes aldehydes like malondialdehyde.

    Formule :C12H13ClN2O
    Degré de pureté :99.4% - 99.97%
    Couleur et forme :Solid
    Masse moléculaire :236.7

    Ref: TM-T16732

    5mg
    39,00€
    10mg
    52,00€
    25mg
    97,00€
    50mg
    169,00€
    100mg
    264,00€
  • JAK-IN-40


    JAK-IN-40 (Compound 46) is an inhibitor of JAK, effectively targeting JAK1, JAK2, and JAK3 with IC50 values of 0.022, 0.759, and 1.601 μM, respectively. It reduces the phosphorylation of STAT3 and inhibits the proliferation of cancer cells Ba/F3 and JAK1-TEL Ba/F3 with GI50 values of 0.614 μM and 0.193 μM. JAK-IN-40 arrests cell cycle progression at the G2/M phase in H1975 and H2087 cells, leading to apoptosis. Additionally, JAK-IN-40 exhibits a synergistic anti-tumor effect when used in combination with Osimertinib.
    Formule :C26H32N8O3S
    Couleur et forme :Solid
    Masse moléculaire :536.65

    Ref: TM-T205062

    10mg
    À demander
    50mg
    À demander
  • Obestatin (human)

    CAS :
    Obestatin (human) is an endogenous ligand for G-protein eurythmic entity 39 formed by shearing of preproghrelin and can be used to study obesity.
    Formule :C116H176N32O33
    Degré de pureté :99.75%
    Couleur et forme :Solid
    Masse moléculaire :2546.83

    Ref: TM-T38470

    1mg
    80,00€
    5mg
    215,00€
    10mg
    323,00€
    25mg
    505,00€
    50mg
    675,00€
    100mg
    909,00€
  • AY-4


    AY-4 (Compound AY-4) is a potent PROTAC degrader targeting FTH1, with a dissociation constant (Kd) of 3.17 nM. It effectively increases intracellular ferrous (Fe2+) and ferric (Fe3+) ion levels. AY-4 is a potential anticancer candidate that regulates iron homeostasis through ferritin degradation, enhancing the efficacy of existing drugs. Additionally, AY-4 significantly reduces FTH1 levels in breast cancer cells.
    Couleur et forme :Odour Solid

    Ref: TM-T211240

    10mg
    À demander
    50mg
    À demander
  • TrxR1-IN-2


    TrxR1-IN-2 (Compound 6a) acts as a TrxR1 inhibitor that covalently bonds with the Cys475 and Sec498 sites of TrxR1. This interaction hampers TrxR1 activity, resulting in a redox homeostasis disruption and inducing apoptosis and ferroptosis.
    Formule :C19H23NO6
    Couleur et forme :Solid
    Masse moléculaire :361.389

    Ref: TM-T204985

    10mg
    À demander
    50mg
    À demander
  • Iturin A

    CAS :
    Iturin A: antifungal compound targeting cell membranes, forms ion pores in yeast/fungi.
    Couleur et forme :Solid

    Ref: TM-T40600

    5mg
    À demander
  • Zaptuzumab

    CAS :
    Zaptuzumab (AD5-10) is a humanized monoclonal antibody targeting death receptor 5 (DR5) with high selective binding affinity. It specifically induces cancer cell death through caspase-mediated apoptosis and autophagic cell death (ACD). Zaptuzumab can activate antibody-dependent cell-mediated cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC). Additionally, it induces reactive oxygen species (ROS) production and reduces glutathione (GSH) levels. In various xenograft mouse tumor models, Zaptuzumab has demonstrated significant tumor growth inhibition and favorable safety profiles.
    Couleur et forme :Liquid

    Ref: TM-T9901A-1802

    1mg
    À demander
    5mg
    À demander
  • Dual Galectin-3/EGFR-IN-1


    Dual Galectin-3/EGFR-IN-1 (Compound 29) is a dual inhibitor targeting Galectin-3 and EGFR, with dissociation constants (KD) of 52.29 μM and 3.31 μM, respectively. It inhibits TGF-β-induced hepatic stellate cell (HSC) activation, induces apoptosis in LX-2 cells, and shows antifibrotic activity in the liver.
    Formule :C32H41N7O10
    Couleur et forme :Solid
    Masse moléculaire :683.709

    Ref: TM-T204936

    10mg
    À demander
    50mg
    À demander
  • E3 ligase Ligand 36

    CAS :
    E3 ligase Ligand 36 is an E3 ligase ligand that can be utilized for synthesizing PROTACs, such as PROTAC BRM/BRG1 degrader-1.
    Formule :C25H30N4O5S
    Couleur et forme :Solid
    Masse moléculaire :498.6

    Ref: TM-T201850

    10mg
    À demander
    50mg
    À demander
  • C199


    C199 is a PROTAC degrader targeting PRMT4 with a DC50 of 106 nM. It demonstrates high selectivity for PRMT4 compared to other protein arginine methyltransferases. C199 exhibits strong cellular degradation capacity and induces apoptosis in multiple myeloma cell lines. It efficiently eliminates PRMT4 protein through the VHL-proteasome pathway. C199 has a relatively long half-life and shows potent anti-multiple myeloma (MM) activity.
    Couleur et forme :Odour Solid

    Ref: TM-T211244

    10mg
    À demander
    50mg
    À demander
  • FAK-IN-25


    FAK-IN-25 (4c) is an inhibitor of FAK with an IC50 value of 50.98 nM. It induces apoptosis and causes cell cycle arrest in the G1 phase, making it relevant for cancer research.
    Formule :C22H13ClN4OS2
    Couleur et forme :Solid
    Masse moléculaire :448.95

    Ref: TM-T207166

    10mg
    À demander
    50mg
    À demander
  • 1D09C3

    CAS :
    1D09C3 is a fully humanized anti-HLA-DR monoclonal antibody. It induces cell apoptosis (apoptosis) and death through a cascade of reactions, including reactive oxygen species (ROS) production, JNK activation, mitochondrial membrane depolarization, and the release of AIF from mitochondria. In xenograft models with JVM-2 cells and GRANTA-519 cells in mice, 1D09C3 demonstrated significant antitumor activity, improving overall survival and median survival time. This compound is applicable in cancer research, including studies on chronic lymphocytic leukemia (CLL).
    Couleur et forme :Liquid

    Ref: TM-T9901A-1797

    1mg
    À demander
    5mg
    À demander
  • BRD9 ligand-5

    CAS :
    BRD9 Ligand-5 (Compound 172-11) serves as a ligand for the target protein in PROTAC applications. It is utilized in the synthesis of CFT8634.
    Formule :C17H19NO4
    Couleur et forme :Solid
    Masse moléculaire :301.34

    Ref: TM-T201421

    10mg
    À demander
    50mg
    À demander